Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Vegetable tar except shampoos in concentrations of 5% or less III SEP / 98
Velaglucerase alfaPDL I DEC / 13
VelpatasvirPDL I AUG / 16
Vemurafenib or its salts or derivativesPDL I DEC / 13
Venetoclax or its saltsPDL I NOV / 16
Venlafaxine or its saltsPDL I DEC / 13
Verapamil or its saltsPDL I DEC / 13
Veratrum album or its alkaloids or their saltsPDL

For human use.

I DEC / 13
Veratrum viride or its alkaloids or their saltsPDL

For human use

I DEC / 13
Vernakalant or its saltsPDL I APR / 17
Verteporfin or its salts or derivatives PDL I DEC / 13
VidarabinePDL I DEC / 13
Vigabatrin or its salts or derivativesPDL I DEC / 13
Vilanterol or its saltsPDL

Including but not limited to Vilanterol trifenatate

I DEC / 13
Vilazodone or its saltsPDL I AUG / 15
Vinblastine or its saltsPDL I DEC / 13
Vincristine or its saltsPDL I DEC / 13
Vindesine or its saltsPDL I DEC / 13
Vinorelbine or its saltsPDL I DEC / 13
Viomycin or its salts or derivativesPDL I DEC / 13
Virginiamycin or its salts or derivativesPDL I DEC / 18
VismodegibPDL I DEC / 13
Vitamin APDL

For human use  - in oral dosage forms containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A.

I DEC / 13
Vitamin B12 with Intrinsic Factor ConcentratePDL I DEC / 13
Vitamin DPDL

For human use - in oral dosage form containing more than 62.5 mcg or 2,500 International Units of Vitamin D per dosage form, or where the largest recommended daily dosage shown on the label would result in the daily intake by that person of more than 62.5 mcg or 2,500 International Units of Vitamin D

I FEB / 21
Vitamin KPDL

For human use - except Vitamin K1 or Vitamin K2 sold (a) for external use in humans; or (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less.

I DEC / 13
Vitamins

in injectable form, except those listed in Schedule I

II SEP / 98
Vitamins in injectable form for parenteral nutrition I JAN / 03
Vorapaxar or its saltsPDL I AUG / 16
Voretigene neparvovecPDL I DEC / 20
VoriconazolePDL I DEC / 13
VorinostatPDL I DEC / 13
Vortioxetine or its saltsPDL

including but not limited to vortioxetine hydrobromide

I DEC / 14
Voxilaprevir or its saltsPDL I SEP / 17
Xanthinol nicotinatePDL I DEC / 13
Xylazine or its saltsPDL I DEC / 13
Xylometazoline and it salts in nasal preparations for pediatric use (0.05%) II SEP / 98
Xylometazoline and its salts

in nasal preparations for adults (0.1%)

U SEP / 98
Yellow Fever vaccine I FEB / 02
Yohimbine or its saltsPDL I DEC / 13
Zafirlukast or its saltsPDL I DEC / 13
Zalcitabine or its saltsPDL I DEC / 13
Zaleplon or its salts or its derivativesPDL I NOV / 18
Zanamivir or its salts or derivativesPDL I DEC / 13
Zanubrutinib or its saltsPDL I MAY / 21
ZeranolC I SEP / 98
ZidovudinePDL I DEC / 13
Zinc chloride in injectable form for parenteral nutrition I JAN / 03
Zinc sulfate in injectable form for parenteral nutrition I JAN / 03
Zipeprol and any salt thereofC I NOV / 20
Ziprasidone or its saltsPDL I DEC / 13
Zoledronic acid or its salts or derivativesPDL I DEC / 13
Zolmitriptan or its saltsPDL I DEC / 13
Zolpidem and any salt thereofTS I JAN / 03
Zomepirac or its saltsPDL I DEC / 13
Zopiclone or its saltsPDL I DEC / 13
ZucapsaicinPDL I DEC / 13
Zuclopenthixol or its salts or derivativesPDL

Including but not limited to zuclopenthixol decanoate, zuclopenthixol hydrochloride.

I DEC / 13

1858 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act